Coenzyme

Page 1

Journal of Equine Veterinary Science xxx (2012) 1-3

Journal of Equine Veterinary Science journal homepage: www.j-evs.com

Original Research

Coenzyme Q10 in Equine Serum: Response to Supplementation Stephen T. Sinatra MD a, Raj K. Chopra MS b, Stanley Jankowitz MBA b, David W. Horohov PhD c, Hemmi N. Bhagavan PhD b a

University of Connecticut School of Medicine, Farmington, CT 06030, USA GelTec/Tishcon Corporation, Westbury, NY 11590, USA c University of Kentucky, Lexington, KY 40546 b

a r t i c l e i n f o

a b s t r a c t

Article history: Received 18 January 2012 Received in revised form 10 April 2012 Accepted 2 May 2012 Available online xxx

Although the importance of coenzyme Q10 (CoQ10) in health and disease and its critical role in cellular bioenergetics have been well established in various species, there is a total lack of information on the role of CoQ10 in horses. Therefore, the present study was undertaken first to ascertain the occurrence of CoQ10 and/or possibly other homologs of coenzyme Q (CoQ) in horse serum, and then to examine the response to CoQ10 supplementation on serum CoQ10 concentration. The study was carried out with 2-yearold Thoroughbred horses. Total CoQ (reduced and oxidized forms) in serum was assayed by high-performance liquid chromatography. The data show that horse serum contains CoQ as CoQ10, at a much lower concentration as compared with that of humans and several other species. There is no evidence for the presence of coenzyme Q9 or other homologs of CoQ. On supplementation with CoQ10 at 800 mg a day (1.47 mg/kg body weight), there was a significant increase in serum CoQ10 concentration, approximately 2.7-fold at 60 days. CoQ10 supplementation at this dosage was found to be safe and well tolerated. Additional studies are needed to examine whether maintaining higher serum CoQ10 concentrations is of potential health benefit to the horses, as assessed by selected biochemical markers and also in terms of performance. Ó 2012 Elsevier Inc. All rights reserved.

Keywords: Coenzyme Q10 Ubiquinone Thoroughbred horses Serum coenzyme Q10 Coenzyme Q10 supplementation

1. Introduction Coenzyme Q (CoQ) refers to a homologous series of naturally occurring compounds that contain a benzoquinone ring structure with an isoprenoid side chain of varying lengths. CoQ is also known as ubiquinone because of its ubiquitous distribution in nature. In humans and several other mammalian species, the side chain is composed of 10 isoprene units, hence it is called coenzyme Q10 (CoQ10). The chemical nomenclature of CoQ10 is 2,3-dimethoxy-5methyl-6-decaprenyl-1,4-benzoquinone. Although CoQ10 functions like a vitamin, it is not considered one because CoQ10 (or its homolog) is synthesized in the body in humans and other species of animals. Corresponding author at: Hemmi N. Bhagavan, PhD, Tishcon Corporation, 50 Sylvester Street, Westbury, NY 11590. E-mail address: hemmin@msn.com (H.N. Bhagavan). 0737-0806/$ - see front matter Ó 2012 Elsevier Inc. All rights reserved. doi:10.1016/j.jevs.2012.05.001

CoQ10 has a fundamental role in cellular bioenergetics as a cofactor in the mitochondrial electron transport chain (respiratory chain) and is therefore essential for the production of biological/chemical energy in the form of adenosine triphosphate [1]. It functions as a mobile redox agent shuttling electrons and protons in the electron transport chain. The redox functions of CoQ10 extend beyond its role in the mitochondria. Furthermore, CoQ10 in its reduced form as the hydroquinone (called ubiquinol) is a potent lipophilic antioxidant and is capable of recycling and regenerating other antioxidants such as tocopherol and ascorbate. Other important functions of CoQ10 such as cell signaling and gene expression have also been recognized [2]. The role of CoQ10 in health and disease and the benefits of CoQ10 supplementation in various conditions have been documented [3,4]. Although the importance of CoQ10 in humans and several other species of animals has been well recognized,


2

S.T. Sinatra et al. / Journal of Equine Veterinary Science xxx (2012) 1-3

there is a total lack of information on CoQ in horses. We therefore sought to examine first the presence of CoQ10 in horse serum, and also of other homologs if any, and then to study the effect of oral CoQ10 supplementation on serum CoQ10 concentrations. 2. Methods Two-year-old Thoroughbred horses were used in this investigation. The study was carried out in two parts at the Murmur Farm in Darlington, Maryland. In the first part, six horses were used to ascertain the occurrence of CoQ in blood (serum) and establish baseline serum CoQ values. The second part of the study involved six additional horses that were given an oral nutritional supplement containing CoQ10 (as HydroQ-Sorb; Gel-Tec/ Tishcon Corp., Westbury, NY) at a daily dose of 800 mg for 60 days (administered with the feed). The weight of the horses ranged from 520 to 570 kg, with a mean of 545 kg, and the CoQ10 dosage calculated on a body weight basis was 1.47 mg/kg. This was based on a typical dose used in humans, as there are no other data in horses to compare with. The dose used here is comparable with a daily dose of 100 mg for a human weighing 70 kg (1.43 mg/kg). Blood samples were drawn at baseline and at 30 days and 60 days, and serum was separated and kept frozen at 26 C for 6-12 months before being analyzed for CoQ. Total CoQ in serum (ubiquinone þ ubiquinol) was determined by high-performance liquid chromatography [5,6] using tocol and coenzyme Q9 (CoQ9) as internal standards. Data were analyzed using an analysis of variance, and significance was set at P .05. 3. Results The data show that horse serum contains CoQ as CoQ10. There was no evidence for the presence of CoQ9, as seen in the case of rats, or any other form of CoQ. The baseline CoQ10 in the serum of six resting horses ranged from 0.188 to 0.309 mg/mL, with a mean value of 0.226 0.043 mg/mL. The individual values are shown in Table 1. The mean baseline serum CoQ10 in the second part of the study with six additional horses was similar, ranging from 0.138 to 0.273 mg/mL (mean: 0.187 0.048 mg/mL), and there was no significant difference between the two baseline values. On CoQ10 supplementation (800 mg a day), there was a significant increase in serum CoQ10 concentrations at 30 days (mean: 0.407 0.182 mg/mL) and at 60 days (mean: 0.511 0.192 mg/mL). The differences between baseline and 30-day, as well as baseline and

Table 1 Baseline serum CoQ10 concentration in Thoroughbred horses (mg/mL) Horse Number

Concentration (mg/mL)

1A 2A 3A 11A 24A 25A Mean

0.188 0.220 0.228 0.309 0.213 0.200 0.226 0.043

Table 2 Serum CoQ10 concentration in Thoroughbred horses after CoQ10 supplementation (mg/mL) Horse Number

Baseline

30 Days

60 Days

5A 6A 8A 12A 19A 22A Mean P (with baseline)

0.167 0.273 0.138 0.167 0.166 0.212 0.187 0.048

0.319 0.753 0.234 0.408 0.312 0.413 0.407 0.182 ¼.047

0.377 0.846 0.280 0.543 0.503 0.516 0.511 0.192 <.004

60-day, values were significant at P < .05. The individual serum CoQ10 values for the second set of horses before and after CoQ10 supplementation are shown in Table 2. The CoQ10 supplement was found to be safe and well tolerated by all the horses, and there were no gastrointestinal problems or any other side effects. 4. Discussion This study documents for the first time the presence of CoQ10 and its quantitation in the serum of horses. There was no evidence for the occurrence of CoQ9 or any other CoQ homolog in horse serum. It may be noted that because total CoQ10 (ubiquinone þ ubiquinol) was determined in this study, stability of ubiquinol in frozen plasma at 14 F was not an issue. Ubiquinol is unstable in plasma/serum and is readily oxidized to ubiquinone, unless the sample is frozen immediately and stored at 80 C. The data show that the baseline serum CoQ10 concentration in resting Thoroughbred horses is much lower than that in humans, in whom the normal value for plasma/ serum CoQ10 is approximately 0.8 mg/mL [7]. The serum CoQ10 concentration in horses is also much lower than that in other species of animals. For instance, the reported mean value for baboons is 0.76 mg/mL [8], for Yorkshire swine is 0.39 mg/mL [9], and for rabbits is 1.09 mg/mL [10]. It is comparable with that in dogs (coonhounds) at 0.21 mg/mL [11]. In the case of rats, known to contain predominantly CoQ9, a value of 0.44 mg/mL for total CoQ in plasma has been reported [12]. Following CoQ10 supplementation, there was a significant increase in serum CoQ10 values, as expected, approximately 2-fold at 30 days and beginning to plateau or perhaps plateaued at 2.7-fold at 60 days. Additional data points would have clarified whether steady-state levels had been achieved at 60 days at a daily dose of 800 mg of CoQ10 (1.47 mg/kg). Plateauing of plasma CoQ10 values has been observed in human subjects in 3-4 weeks at a daily dose of 120 mg or at 1.71 mg/kg [13]. It may be noted that the dosage of CoQ10 for horses in this study at 1.47 mg/kg body weight is rather low as compared with therapeutic dosages used in numerous human studies. Daily doses as high as 3,000 mg have been tested in human subjects without any adverse effects [14]. CoQ10 supplementation at the specified dosage was found to safe and well tolerated by the 2-year-old Thoroughbred horses, and there were no signs of any gastrointestinal problems or any other side effects. It may be


S.T. Sinatra et al. / Journal of Equine Veterinary Science xxx (2012) 1-3

noted that the serum CoQ10 response of one horse (8A) was poor as compared with the others in the group (Table 2), and this is similar to the situation in humans, where there are some who are poor responders to CoQ10 supplementation. Additional studies are needed to evaluate whether CoQ10 supplementation at this low dosage (or at much higher doses) is of potential benefit to the Thoroughbred horses, as revealed by biochemical markers of oxidative stress and inflammation, and also as evidenced by their performance. Furthermore, based on the fundamental role of CoQ10 in cellular energy production and the oxidant/ antioxidant balance, it will be important to determine the optimum concentration of serum/plasma CoQ10 that can be achieved by oral CoQ10 supplementation that would afford significant benefit with respect to not only overall health but also performance of the horses. In this context, it may be noted that the exercise-induced pulmonary hemorrhage (EIPH) continues to be a major problem in the Thoroughbred industry. EIPH has been related to an oxidant/antioxidant imbalance in affected horses [15]. As oxidants increase the synthesis of vasoconstrictor agents, pulmonary vascular pressure (considered as the primary cause of EIPH) may be further increased and results in the rupture of pulmonary capillaries [16]. Therefore, it would be of immense practical significance to determine whether supplementation with a nutrient such as CoQ10, by virtue of its role in cellular bioenergetics, membrane stabilization, and mitigating oxidative stress, could reduce the risk for EIPH and thus obviate the need for potent diuretics, as is the current practice. Acknowledgment The authors express their gratitude to Mr. Corby Caiazzo for the excellent care of the horses at Murmur Farm, Darlington, Maryland, and offer their special thanks to Audrey Murray and Edgar Allen Murray for their keen interest in this study.

3

References [1] Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995;1271:195-204. [2] Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr 2001;20:591-8. [3] Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006; 40:445-53. [4] Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition 2010;26:250-4. [5] Rousseau G, Varin F. Determination of ubiquinone-9 and 10 levels in rat tissues and blood by high-performance liquid chromatography with ultraviolet detection. J Chromatogr Sci 1998;36:247-52. [6] Tang PH, Miles MV, DeGrauw A, Hershey A, Pesce A. HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma. Clin Chem 2001;47:256-65. [7] Miles MV, Horn PS, Tang PH, Morrison JA, Miles L, DeGrauw T, et al. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta 2004;347:139-44. [8] Wang XL, Rainwater DL, Mahaney MC, Stocker R. Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. Am J Clin Nutr 2004; 80:649-55. [9] Serebruany VL, Herzog WR, Atamas SP, Gurbel PA, Rohde M, Mortensen SA, et al. Hemostatic changes after dietary coenzyme Q10 supplementation in swine. J Cardiovasc Pharmacol 1996; 28:175-81. [10] Shiomi M, Yamada S, Amano Y, Nishimoto T, Ito T. Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipidrich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions. Br J Pharmacol 2008;154:949-57. [11] Zaghloul AA, Gurley B, Khan M, Bhagavan H, Chopra R, Reddy I. Bioavailability assessment of oral coenzyme Q10 formulations in dogs. Drug Dev Ind Pharm 2002;28:1195-200. [12] Kon M, Kimura F, Akimoto T, Tanabe K, Murase Y, Ikemune S, et al. Effect of Coenzyme Q10 supplementation on exercise-induced muscular injury of rats. Exerc Immunol Rev 2007;13:76-88. [13] Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res 1998;68:109-13. [14] Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 2007; 7(Suppl):S78-88. [15] Kirschvink N, de Moffarts B, Lekeux P. The oxidant/antioxidant equilibrium in horses. Vet J 2008;177:178-91. [16] Mills PC, Higgins AJ. Oxidant injury, nitric oxide and pulmonary vascular function: implications for the exercising horse. Vet J 1997;153:125-48.


PRODUCT USED IN STUDY

®

The WINNING EDGE

SM

®

DOUBLE DIAMOND I FORMULA FOR PEAK-EQUINE-PERFORMANCE

EQUINE ENERGY & RECOVERY-Powerhouse

SM

Studies Have Shown This Formula Helps Support & Maintain Healthy Inflammatory-Responses In Equine* RI

• Mitochondrial Powerhouse

RIAN FORM UL

NA

VETE

AT E D

D

RU

TM

G FRE

E

• Helps Energize & Maintain Optimal Mitochondrial Functioning & Peak-Equine-Performance • Helps Support Recovery After Performance Events • Studies Show That Supplementation Helps Support & Maintain A Healthy Response In Young Race Horses During TrainingSM †† • Patented Technologies For Enhanced Bioavailability Journal of Equine Veterin ary

Journal

e of Equin

Veterinary

) xxx (2012 Science

uine l of Eq

Journa

journ

me al ho

1-11

: www

.j-evs

J. of Kent ersity PhD a Richard er, Univ , CT rohov arch Cent Farmington, W. Ho t BS ne Rese icine, David k Equi ancour of Med ell Gluc School dra Bet ce, Maxw ecticut Alejan y Scien phis, TN of Conn

history: uary 2012 Article 29 Febr Received in revised form Received 2012 h 23 Marc 28 March 2012 Accepted online xxx Available Keywords: Exercise mation In flam n Adaptatio dehyde Malondial Lactate ntation Suppleme

of cause ic tion common econom most as of is the that horses e, as well was reported ss in ormanc 0s, it because Lamene etic perf early 198 horses was ed athl In the than 80% diminish al loss [1] . s for race that more d ing day and anim the lost train data indicate nt of % riRece . 67.6 of Vete ess [2] rtment of ersity oflamen hov, Depa

duc 1. Intro

er, Univ W. Horo arch Cent David e Rese or at: ding auth ell Gluck Equin . Correspon Maxw Horohov) , KY. (D.W. ce, 128H Lexington ved. @uky.edu nary Scien 40546-0099 s reser , All right DWHoro2 Kentucky address: ier Inc. E-mail 2012 Elsev matter - see front 3.017 6/$ 012.0 0737-080 16/j.jevs.2 doi: 10.10

homepa

c

,

Response b

of Connec ticut School GelTec/Tishco of Medici n Corpor ne, Farmin ation, Westbu University gton, CT of Kentuc ry, NY 11590, 06030, USA ky, Lexing USA ton, KY 40546

b c

ge: www .j-e

, Stanley

Science

vs.com

to Supple me

ntation

Jankowit

z MBA

b

, David W.

Horohov

PhD

c

,

a r t i c l e i n f o

Article history : Received 18 Januar y 2012 Received in revised form 10 April 2012 Accepted 2 May 2012 Available online xxx Keywords: Coenzyme Q10 Ubiquinone Thoroughbred Serum coenzy horses me Q10

a b s t r a c t Although the impor tance of role in cellula r bioenergetics coenzyme Q10 (CoQ1 lack ofinfo 0) in health have been rmation well establ and on the undertaken ished in variou disease and its first to ascert role of CoQ10 in critical s species, horses. Theref coenzyme ain the occurr there is a Q ore, the ence of CoQ10 supplementa (CoQ) in horse present study total serum, and and/or possib tion on serum then to old Thoro ly other homo was CoQ10 conce examine ughbred logs of ntration. the respon horses. Total by high-p The study se to CoQ10 CoQ erformance was carried liquid chrom (reduced and oxidiz CoQ as CoQ10 out with ed forms) atography. 2-yearin serum several other , at a much lower The data was assaye show that concentratio species. There d horse serum homologs n as compa is no eviden of CoQ. On contai red with ce for the that of human ns weight), supplementa presence there was tion with s and of coenz a signi 2.7-fold at CoQ10 at yme Q9 ficant 800 mg 60 days. or other CoQ10 supple increase in serum a day (1.47 tolerated. CoQ10 conce mg/kg body Additional mentation ntration, studies are at this dosag CoQ10 conce approximate needed to e was found ntrations ly examine is of biochemical to be safe whether and well markers and potential health bene maintaining also in terms higher serum fit to the horses, as of perfor mance. assessed by selecte d 2012 Elsevie r Inc. All rights reserv ed.

s of Coenzyme Q10 supple mentation symptom the mild e, joint, and ory es from tissu flammat t cise rang affecting soft in r a c ies rous exer g the on the to vigo ilitating injur regardin available onse lable racing to deb ory resp ormation tion is avai ing for soreness t deal ofinf flammat rma ing train young Thor The in muscle grea less info es undergo p of onset e is a in non a grou athletes, hors in g est an we delayed- ough ther cise youn ion, hum is inter Alth to exer cise in cise in flammat there bone. to exer to exer kine response of the Because ced in to half cyto response ory response training. exercise-indu folnt fed ssed the mat initial s1.were Introduction suppleme their liorate in flam we asse 2 year at or ame a nutritional Here, during aged control of collected r es s , an d horses horses careers. es to were effect d race hbred st approach flammatory fi ve Thoroug samples d, ox i dat i v eCoenz oughbre of yme Q blood ologic in i c a ci effect (CoQ) refers heral pharmac ined the anti- ing. Twentyn. of l a c t endentnatura essio to a homo occur ing. Perip tat i on exprlly ring comp sity-dep logous series also exam ergoing train l race train t h e qu an t i ory ring struct ounds that an inten cytokine gene und or flammat ure with of contain a e was their initia ex er ci s e f ory horses in an isopre benzoquino Ther mat length ugh in s n. flam s. CoQ thro noid side n g th e ne n indicator is also know expressio lowed reduction in their chain of s du r i ubiquitous gene and proi n as ubiqu overall s ti m e varying lemen-distrib ctions v a r i ou cytokine ndialdehyde, d with an inone becau al supp ution in er redu itionother matory nature. In se ofits mammalian te, malo associate exhibited furth ence of nutr . in flam humans nt on lacta itself was evid isoprene reserved species, the side and severa novel rights units, hence ing exercise suppleme chain is comp l All ides train the h prov it is called ier Inc.The chem osed of 10 receiving , this study Althoug ical coenzyme 2012 Elsev , horses mation. such methyl-6-de nomenclature of Q10 (CoQ1 markers mation. As in flam CoQ1 0). capre cise 0 is 2,3-di nyl-1,4-benz functions methoxy-5ofin flam cing postexer oquinone. like a vitam redu Although CoQ10 (or tation horses in, it is not CoQ1

rinar Mem nt of Vete , University , NY Memphis, Departme nt of Medicine on, Westbury University of orati b Departme ratory, hcon Corp bolic Labo c GelTec/Tis Meta piratory t d Cardiores a b s

i n f o i c l e a r t

Q10 in Equ ine

Serum: Stephen T. Sinatra MD a, Raj Hemmi N. K. Chopra Bhagavan MS a PhD b University

.com

on tation s lemen l Supp cehorse tritiona in Young Ra earch al Res and Nu itz MA sion Origin Jankow Exercise kine Expres c Stanley , ect of MS ry Cyto The Eff Chopra ato K. b mm , Raj d a MD Proin fla ining KY T. Sinatr er PhD Tra gton, a , Stephen ucky, Lexin Bloom During

a

journal

Original Rese arch

Coenzyme

ce ry Scien Veterina

page

Science xxx (2012) 1-3

Journal of Equine Vet erinary

its homolog). In 0 considered race [3] is synth andhbred one becau esized in es s specie se Thoroug other issu the body ofof animals. training in humans meness than 80% r lost from e because ofla thei that less l days pleted of tota of years wer rds showed Corresp comonding and 3 author causes ing 50 ration, at: Hemm h the race reco es in train aged 2 Sylvest i N. Bhagav er Street, sed study, Althoug an, PhD, focu Westbury, addres Tishcon Corporacehors race [1] . E-mailhas bees:n hemmi another [4-6] . NY 11590. ar-old n@msn ntion .com (H.N. t on to process the 2-ye d atte Bhagavan). n0737-0rs in this and wen increase of proi iato 806/$ - see on front training are varied, med doi: matter ucti 10.1016 ory -like 2012 Elsevie prod /j.jevs.2012.05. ss one flammat 001 nlamene r Inc. All with the small horm rights reserve role ofin associated uli. Proi are d. on the is which rnal stim b, IL-6, and mation kines, e to exte (IL)-1 In flam ory cyto in respons kin vigorous d interleu induced by flammat produce such as kines - a ) are proteins a (TNF ory cyto factorflammat necrosis tumor

*PATENTED INGREDIENTS IN A PROPRIETARY PATENT PENDING DOUBLE-DIAMOND® I FORMULA

CoQ10 has a fundament as a cofac al role in tor in the cellular bioen mitochond (respiratory ergetics rial electr chain) and on transp production is therefore ort chain of biolog essential ical/chemica adenosine for the triphosphat l energy in the form e [1] . It agent shuttl functions of ing electr as a mobil transport ons and e redox chain. The protons in the beyon redox

electron d its role in the mitoc functions of CoQ1 its reduced 0 extend hondria. form as the Furthermo a potent re, CoQ10 hydroquino lipophilic in ne (called antiox and regen ubiquinol) erating other idant and is capab is le of recycl ascorbate. antioxidants ing Other impor such as tocop signaling tant functi herol and and gene ons of CoQ1 expre [2] . The role 0 such as ssion have cell of CoQ10 also been in health of CoQ10 recognized and diseas suppl e and the documented ementation in variou bene s conditions [3,4] . fits have been Although the importance several other of CoQ1 species of 0 in huma animals has ns and been well recognized ,

©2012 Equine Nutriceuticals, LLC. 257 East Center Street, Manchester, CT 06040 - (855) 647-9729 For more information please refer to: www.EquineNutriceuticals.com

Studies published in the:

Journal of Equine Veterinary Science All trademarks, service marks and trade names referenced in this material are the property of their respective owners.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.